These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 17393722

  • 1. Regulatory aspects of allergen products for immunotherapy--considerations from the viewpoint of manufacturers.
    Kroon AM.
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):49-58; discussion 58-9. PubMed ID: 17393722
    [Abstract] [Full Text] [Related]

  • 2. The regulatory system in europe with special emphasis on allergen products.
    Lorenz AR, Luttkopf D, Seitz R, Vieths S.
    Int Arch Allergy Immunol; 2008; 147(4):263-75. PubMed ID: 18648190
    [Abstract] [Full Text] [Related]

  • 3. Registration trials for specific immunotherapy in Europe: advanced guidance from the new European Medical Agency guideline.
    Gödicke V, Hundt F.
    Allergy; 2010 Dec; 65(12):1499-505. PubMed ID: 20608914
    [Abstract] [Full Text] [Related]

  • 4. Comparison of allergen immunotherapy practice patterns in the United States and Europe.
    Cox L, Jacobsen L.
    Ann Allergy Asthma Immunol; 2009 Dec; 103(6):451-59; quiz 459-61, 495. PubMed ID: 20084837
    [Abstract] [Full Text] [Related]

  • 5. Close collaboration between academia, industry and drug regulators is required in the development of allergen products for specific immunotherapy in children.
    Eichler I, Soriano ES.
    Allergy; 2011 Aug; 66(8):999-1004. PubMed ID: 21426358
    [Abstract] [Full Text] [Related]

  • 6. Regulatory environment for allergen-specific immunotherapy.
    Kaul S, May S, Lüttkopf D, Vieths S.
    Allergy; 2011 Jun; 66(6):753-64. PubMed ID: 21288251
    [Abstract] [Full Text] [Related]

  • 7. The EAMG position on the regulation of existing products for treatment with special reference to named patient products (NPPs).
    Kroon AM.
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2003 Jun; (94):7-14; discussion 14-6. PubMed ID: 15119017
    [Abstract] [Full Text] [Related]

  • 8. European Academy of Allergy and Clinical Immunology task force report on 'dose-response relationship in allergen-specific immunotherapy'.
    Calderón MA, Larenas D, Kleine-Tebbe J, Jacobsen L, Passalacqua G, Eng PA, Varga EM, Valovirta E, Moreno C, Malling HJ, Alvarez-Cuesta E, Durham S, Demoly P.
    Allergy; 2011 Oct; 66(10):1345-59. PubMed ID: 21707645
    [Abstract] [Full Text] [Related]

  • 9. Regulatory Requirements for the Quality of Allergen Products for Allergen Immunotherapy of Food Allergy.
    Englert L, Mahler V, Bonertz A.
    Curr Allergy Asthma Rep; 2021 May 10; 21(5):32. PubMed ID: 33970347
    [Abstract] [Full Text] [Related]

  • 10. [Allergens for specific immunotherapy: authorization and quality criteria of the Paul-Ehrlich-Institut].
    May S, Kaul S, Schröder C, Vieths S.
    Hautarzt; 2006 Oct 10; 57(10):867-74. PubMed ID: 16977441
    [Abstract] [Full Text] [Related]

  • 11. Regulatory aspects of specific immunotherapy in Europe.
    Kaul S, Englert L, May S, Vieths S.
    Curr Opin Allergy Clin Immunol; 2010 Dec 10; 10(6):594-602. PubMed ID: 20864886
    [Abstract] [Full Text] [Related]

  • 12. New regulatory documents and procedures. I: Guideline on clinical trials of SIT products, European Pharmacopoeia, and note for guidance on allergen products.
    Pini C.
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009 Dec 10; 96():187-90; discussion 191-2. PubMed ID: 20799460
    [No Abstract] [Full Text] [Related]

  • 13. Issues in stinging insect allergy immunotherapy: a review.
    Finegold I.
    Curr Opin Allergy Clin Immunol; 2008 Aug 10; 8(4):343-7. PubMed ID: 18596592
    [Abstract] [Full Text] [Related]

  • 14. Sublingual immunotherapy for Japanese cedar pollinosis.
    Okubo K, Gotoh M.
    Allergol Int; 2009 Jun 10; 58(2):149-54. PubMed ID: 19390236
    [Abstract] [Full Text] [Related]

  • 15. Allergen-related approaches to immunotherapy.
    Rolland JM, Gardner LM, O'Hehir RE.
    Pharmacol Ther; 2009 Mar 10; 121(3):273-84. PubMed ID: 19111571
    [Abstract] [Full Text] [Related]

  • 16. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Mar 10; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 17. Development and regulation of monoclonal antibody products: challenges and opportunities.
    Weinberg WC, Frazier-Jessen MR, Wu WJ, Weir A, Hartsough M, Keegan P, Fuchs C.
    Cancer Metastasis Rev; 2005 Dec 10; 24(4):569-84. PubMed ID: 16408162
    [Abstract] [Full Text] [Related]

  • 18. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.
    Senti G, Johansen P, Haug S, Bull C, Gottschaller C, Müller P, Pfister T, Maurer P, Bachmann MF, Graf N, Kündig TM.
    Clin Exp Allergy; 2009 Apr 10; 39(4):562-70. PubMed ID: 19226280
    [Abstract] [Full Text] [Related]

  • 19. [Regulation of natural medicines in Israel and abroad].
    Lavy T, Haran B, Shemer J, Shani S.
    Harefuah; 2000 Nov 10; 139(9-10):339-44, 408, 407. PubMed ID: 11341206
    [Abstract] [Full Text] [Related]

  • 20. The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification.
    van Ree R, Chapman MD, Ferreira F, Vieths S, Bryan D, Cromwell O, Villalba M, Durham SR, Becker WM, Aalbers M, André C, Barber D, Cistero Bahima A, Custovic A, Didierlaurent A, Dolman C, Dorpema JW, Di Felice G, Eberhardt F, Fernandez Caldas E, Fernandez Rivas M, Fiebig H, Focke M, Fötisch K, Gadermaier G, Das RG, Gonzalez Mancebo E, Himly M, Kinaciyan T, Knulst AC, Kroon AM, Lepp U, Marco FM, Mari A, Moingeon P, Monsalve R, Neubauer A, Notten S, Ooievaar-de Heer P, Pauli G, Pini C, Purohit A, Quiralte J, Rak S, Raulf-Heimsoth M, San Miguel Moncin MM, Simpson B, Tsay A, Vailes L, Wallner M, Weber B.
    Allergy; 2008 Mar 10; 63(3):310-26. PubMed ID: 18269676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.